Brief: Pharmena Gets Positive Test Results On 1-MNA Drug In NASH Indication
July 10 (Reuters) - Pharmena SA PHR.WA :
* SAYS GETS POSITIVE RESULTS FROM PRECLINICAL TESTS ON
ANIMAL
MODEL FROM ITS US-BASED UNIT CORTRIA CORPORATION
* PRE-CLINICAL TESTS REGARDED 1-MNA DRUG IN NASH INDICATION
Source text for Eikon: ID:nEM442Zrpa
Further company coverage: PHR.WA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Pharmena SA
See all newsBrief: Pharmena Makes Cession Of Rights And Obligations From Unit Menavitin
Brief: Pharmena Signs Two Distribution Deals For US, Canada And Mexico Markets
Brief: Pharmena 9-Month Net Loss Narrows To 0.7 Mln Zlotys
Brief: Pharmena Plans To Separate Dermocosmetic Business
Brief: Pharmena H1 Net Loss Narrows To 0.6 Mln Zlotys